Here are three things to know.
- Lucid launched the nationwide voluntary recall June 1 after receiving complaints from pharmacists about melted drug capsules.
- The recall applies to 30-count and 90-count bottles of the antidepressant.
- The Food and Drug Administration announced the recall last week, labeling it as a Class II event, meaning the quality issue poses an intermediate threat of illness or death.
More articles on supply chain:
Why this drugmaker invests in clean coal
FDA approves Shire’s ADHD drug: 3 things to know
Dr. Scott Gottlieb: FDA will ‘completely eliminate’ orphan drug backlog
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
